TBRG4 and neoplasm: Conversely, TBRG4 showed a negative correlation with CD96 and TNFSF15 (P < 0.05, R < −0.1), suggesting it may influence pathways that inhibit T cell function, thereby fostering a more immunosuppressive tumor microenvironment.